UTHR vs WAY
United Therapeutics vs Waystar Holding Corp. — AI-powered side-by-side comparison
UTHR
United Therapeutics
72
Buy
VS
WAY
Waystar Holding Corp.
59
Watch
| Metric | UTHR | WAY |
|---|
| AI Score |
72
|
59
|
| Price |
$514.89
|
$24.31
|
| P/E Ratio |
17.05×
|
33.75×
|
| ROE |
18.8%
|
2.9%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
86.1%
|
69.1%
|
| Debt / Equity |
0.00×
|
0.37×
|
| Dividend Yield |
0.0%
|
0.0%
|
| RSI (14) |
52.2
|
60.5
|
| Beta |
0.564
|
0.07
|
| Expected Upside |
+6.4%
|
—
|
AI Committee View
Current Innellis committee reasoning for UTHR versus WAY.
UTHR leads by 13 points.
UTHR scores 72/100 (Buy) versus WAY at 59/100 (Watch).
UTHR Committee View
80% agreement
5 analysts
The primary driver is quarter-over-quarter growth rate is accelerating, not just positive. Most analysts agree, and no major concerns are blocking a stronger rating.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
- Lower Highs / Lower Lows structure confirms bearish price action.
- Risk/reward is unfavorable: 13.5% downside vs 6.4% upside.
WAY Committee View
50% agreement
6 analysts
The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — bollinger bandwidth of 21.4% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- EPS growing 46.4% YoY — Growth
- MACD histogram positive -- bullish momentum — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
- P/E of 35.1 is moderate-to-rich — Value
- ROE of only 3.6% -- cheap may mean cheap for a reason — Value
- Bollinger bandwidth of 21.4% signals elevated volatility — Risk